๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Wuxi
Clinical trial register · China

Clinical Trials in Wuxi, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Wuxi 6
Narrow the registerReset
Recruitment status
Phase
Site location
Wuxi6
All 1 locations
Target enrolment
to

Trials with a site in Wuxi

6 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Clinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
NCT07798778Metastatic Castration-Resistant Prostate Cancer
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1
18
Wuxi
2026-07-30
By invitation
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
NCT07023848Breast Cancer, Gastric Cancer (GC), Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1
10
Wuxi
2025-07-01
By invitation
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
NCT07023861Breast Cancer, Gastric Cancer (GC), Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1
20
Wuxi
2025-07-01
By invitation
Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients
NCT07162779PET CT
Affiliated Hospital of Jiangnan University
Not applicable
5
Wuxi
2024-10-29
By invitation
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
NCT06723665Prostate Cancer
Affiliated Hospital of Jiangnan University
Not applicable
50
Wuxi
2024-01-25
Recruiting
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
NCT06684028Cancer, Solid Malignancies
Affiliated Hospital of Jiangnan University
Not applicable
30
Wuxi
2023-07-12
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/wuxi

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies with a site in Wuxi that also match the filters currently applied.

How many clinical trials are recruiting in Wuxi?

2 of the 6 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wuxi), 6 studies
PhaseStudiesRecruitingShare
Not applicable3150%
Phase EARLY_PHASE13150%

Most active sponsors

Lead sponsors with the most studies (Wuxi)
Lead sponsorStudiesRecruiting
Affiliated Hospital of Jiangnan University62
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.